Consolidated Statement of Profit or Loss (in million Euro)

	Q1 2014	Q1 2015	% change
Revenue	622	622
Cost of sales	(440)	(425)	-3.4%
Gross profit	182	197	8.2%
Selling expenses	(84)	(88)	4.8%
Research & Development expenses	(35)	(36)	2.9%
Administrative expenses	(44)	(44)
Other operating income	16	28	75.0%
Other operating expenses	(20)	(33)	65.0%
Results from operating activities	15	24	60.0%
Interest income (expense) - net Interest income	(4) -	(4) -
Interest expense	(4)	(4)
Other finance income (expense) - net	(10)	(13)	30.0%
Other finance income	1	1
Other finance expense	(11)	(14)	27.3%
Net finance costs	(14)	(17)	21.4%
Profit (loss) before income taxes	1	7	600.0%
Income tax expense	-	(4)
Profit (loss) for the period	1	3	200.0%
Profit (loss) attributable to:
Owners of the Company	(1)	2
Non-controlling interests	2	1	-50.0%

Results from operating activities	15	24	60.0%
Restructuring and non-recurring items	(1)	(4)
Recurring EBIT	16	28	75.0%

Outstanding shares per end of period	167,751,190	167,751,190
Weighted number of shares used for calculation	167,751,190	167,751,190
Earnings per share (€)	(0.004)	0.013

Consolidated Statements of Comprehensive Income for the quarter ending March 2014 / March 2015 (in million Euro)

	Q1 2014	Q1 2015
Profit / (loss) for the period	1	3
Other Comprehensive Income, net of tax
Items that may be reclassified subsequently to profit or loss:
Exchange differences:	(4)	24
Exchange differences on translation of foreign operations	(4)	36
Exchange differences on net investment hedge	-	(12)
Income tax on exchange differences on net investment hedge	-	-
Cash flow hedges:	2	0
Effective portion of changes in fair value of cash flow hedges	(2)	(7)
Changes in the fair value of cash flow hedges reclassified to profit or loss	-	6
Adjustments for amounts transferred to initial carrying amount of hedged items	4	1
Income taxes	-	-
Available-for-sale financial assets:	-	2
Changes in fair value of available-for-sale financial assets	-	2
Income taxes	-	-
Items that will not be reclassified subsequently to profit and loss:	-	-
Remeasurements of the net defined benefit liability	-	-
Total other Comprehensive Income for the period, net of tax		26

Total Comprehensive Income for the period attributable to:	(1)	29
Owners of the Company	1	22
Non-controlling interests	(2)	7

	31/12/2014	31/03/2015
ASSETS

Non-current assets	1,039	1,058
Intangible assets	615	634
Property, plant and equipment	234	231
Investments	17	18
Deferred tax assets	173	175
Current assets	1,509	1,639
Inventories	512	577
Trade receivables	538	560
Current tax assets	107	109
Other receivables and other assets	120	125
Deferred charges	34	45
Derivative financial instruments	2	5
Cash and cash equivalents	196	218
Total assets	2,548	2,697

EQUITY AND LIABILITIES
Equity	146	175
Equity attributable to owners of the Company	93	115
Share capital	187	187
Share premium	210	210
Retained earnings	709	711
Reserves	(92)	(90)
Translation reserve	(16)	2
Post-employment benefits: remeasurements of the net defined benefit liability	(905)	(905)
Non-controlling interests	53	60
Non-current liabilities	1,443	1,452
Liabilities for post-employment and long-term termination benefit plans	1,267	1,289
Other employee benefits	12	12
Loans and borrowings	125	112
Provisions	14	15
Deferred income	2	2
Deferred tax liabilities	23	22
Current liabilities	959	1,070
Loans and borrowings	197	200
Provisions	155	160
Trade payables	230	257
Deferred revenue and advance payments	125	176
Current tax liabilities	56	60
Other payables	85	87
Employee benefits	93	113
Deferred income	4	5
Derivative financial instruments	14	12
Total Equity and Liabilities	2,548	2,697

	Q1 2014	Q1 2015
Profit (loss) for the period	1	3
Adjustments for:
Depreciation, amortization and impairment losses	18	16
Changes in fair value of derivative financial instruments	0	1
Granted subventions	(2)	(2)
(Gains) / losses on sale of non-current assets	0	0
Net finance costs	14	17
Income tax expense	0	4
	31	39
Change in inventories	(4)	(43)
Change in trade receivables	11	0
Change in trade payables	(5)	21
Change in deferred revenue and advance payments	32	43
Change in other working capital	(17)	(12)
Change in non-current provisions	(20)	(17)
Change in current provisions	8	17
Cash generated from operating activities	36	48
Income taxes paid	(5)	5
Net cash from / (used in) operating activities	31	53
Interest received	1	1
Dividends received	0	0
Proceeds from sale of intangible assets	2	0
Proceeds from sale of property, plant and equipment	1	1
Acquisition of intangible assets	(1)	(1)
Acquisition of property, plant and equipment	(6)	(7)
Changes in lease portfolio	2	0
Change in other investing activities	0	2
Net cash from / (used in) investing activities	(1)	(4)
Interest paid	(4)	(3)
Proceeds from borrowings	0	0
Repayment of borrowings	(10)	(10)
Other financial flows	1	(23)
Net cash from / (used in) financing activities	(13)	(36)
Net increase (decrease) in cash and cash equivalents	17	13
Cash and cash equivalents at January 1	125	194
Effect of exchange rate fluctuations	(2)	10
Cash and cash equivalents at end of the period	140	217

	ATTRIBUTABLE TO OWNERS OF THE COMPANY
in million Euro	Share capital	Share premium	Retained earnings	Reserve for own shares	Revaluation reserve	payment reserve Share-based	Hedging reserve	Remeasurements of the net defined benefit liability	Translation reserve	Total	CONTROLLING S T S INTERE ON N	TOTAL EQUITY
Balance at January 1, 2014	187	210	664	(82)	1	-	(10)	(617)	(28)	325	43	368
Comprehensive income for the period Profit (loss) for the period	- -	- -	(1) -	- -	- -	- -	- 2	- -	- (3)	(1) (1)	2 (1)	1 (2)
Other comprehensive income, net of tax Total comprehensive income for the period	-	-	(1)	-	-	-	2	-	(3)	(2)	1	(1)
Balance at March 31, 2014	187	210	663	(82)	1	-	(8)	(617)	(31)	323	44	367

Balance at January 1, 2015	187	210	709	(82)	1	-	(11)	(905)	(16)	93	53	146
Comprehensive income for the period Profit (loss) for the period	-	-	2	-	-	-	-	-	-	2	1	3
Other comprehensive income, net of tax	-	-	-	-	2	-	-	-	18	20	6	26
Total comprehensive income for the period	-	-	2	-	2	-	-	-	18	22	7	29
Balance at March 31, 2015	187	210	711	(82)	3	-	(11)	(905)	2	115	60	175